Peters E - Search Results

1

Ex-Vivo Modeling for Heritability Assessment and Genetic Mapping in Pharmacogenomics.

Motsinger-Reif A, Brown C, Havener T, Hardison N, Peters E, Beam A, Everrit L, McLeod H. Motsinger-Reif A, et al. Among authors: peters e. Proc Am Stat Assoc. 2011 Jul-Aug;2011:306-318. Proc Am Stat Assoc. 2011. PMID: 30627054 Free PMC article.

2

Identification and replication of loci involved in camptothecin-induced cytotoxicity using CEPH pedigrees.

Watson VG, Motsinger-Reif A, Hardison NE, Peters EJ, Havener TM, Everitt L, Auman JT, Comins DL, McLeod HL. Watson VG, et al. Among authors: peters ej. PLoS One. 2011 May 5;6(5):e17561. doi: 10.1371/journal.pone.0017561. PLoS One. 2011. PMID: 21573211 Free PMC article.

3

Pharmacogenomic characterization of US FDA-approved cytotoxic drugs.

Peters EJ, Motsinger-Reif A, Havener TM, Everitt L, Hardison NE, Watson VG, Wagner M, Richards KL, Province MA, McLeod HL. Peters EJ, et al. Pharmacogenomics. 2011 Oct;12(10):1407-15. doi: 10.2217/pgs.11.92. Pharmacogenomics. 2011. PMID: 22008047 Free PMC article.

4

Association of thymidylate synthase variants with 5-fluorouracil cytotoxicity.

Peters EJ, Kraja AT, Lin SJ, Yen-Revollo JL, Marsh S, Province MA, McLeod HL. Peters EJ, et al. Pharmacogenet Genomics. 2009 May;19(5):399-401. doi: 10.1097/FPC.0b013e328329fdec. Pharmacogenet Genomics. 2009. PMID: 19339911

5

Ability of whole-genome SNP arrays to capture 'must have' pharmacogenomic variants.

Peters EJ, McLeod HL. Peters EJ, et al. Pharmacogenomics. 2008 Nov;9(11):1573-7. doi: 10.2217/14622416.9.11.1573. Pharmacogenomics. 2008. PMID: 19018710 No abstract available.

6

Influence of ethnicity on pharmacogenetic variation in the Ghanaian population.

Yen-Revollo JL, Van Booven DJ, Peters EJ, Hoskins JM, Engen RM, Kannall HD, Ofori-Adjei D, McLeod HL, Marsh S. Yen-Revollo JL, et al. Among authors: peters ej. Pharmacogenomics J. 2009 Dec;9(6):373-9. doi: 10.1038/tpj.2009.28. Epub 2009 Jun 23. Pharmacogenomics J. 2009. PMID: 19546880

7

Intranasal racemic ketamine maintenance therapy for patients with treatment-resistant depression: a naturalistic feasibility study.

Halpape K, Pashovitz R, Wanson A, Hooper M, Peters EM. Halpape K, et al. Among authors: peters em. BMC Psychiatry. 2025 Jan 7;25(1):23. doi: 10.1186/s12888-024-06448-x. BMC Psychiatry. 2025. PMID: 39773202

8

Pharmacokinetics of Oral Cannabinoid Δ8-Tetrahydrocannabivarin and Its Main Metabolites in Healthy Participants.

Sempio C, Campos-Palomino J, Klawitter J, Peters EN, MacNair L, Haghdoost M, Bonn-Miller MO, Harrison A, Babalonis S, Christians U, Klawitter J. Sempio C, et al. Among authors: peters en. Pharmaceuticals (Basel). 2024 Nov 27;17(12):1603. doi: 10.3390/ph17121603. Pharmaceuticals (Basel). 2024. PMID: 39770444

9

Duration of Antibiotic Treatment for Foot Osteomyelitis in People with Diabetes.

Gramberg MCTT, Torensma B, van Asten S, Sieswerda E, Sabelis LWE, den Heijer M, de Vries R, de Groot V, Peters EJG. Gramberg MCTT, et al. Among authors: peters ejg. Antibiotics (Basel). 2024 Dec 4;13(12):1173. doi: 10.3390/antibiotics13121173. Antibiotics (Basel). 2024. PMID: 39766562 Review.

10

Comorbid conditions and survival among Black women with ovarian cancer.

Richards AR, Johnson CE, Montalvo NR, Alberg AJ, Bandera EV, Bondy M, Collin LJ, Cote ML, Hastert TA, Haller K, Khanna N, Marks JR, Peters ES, Qin B, Staples J, Terry PD, Lawson A, Schildkraut JM, Peres LC. Richards AR, et al. Among authors: peters es. Cancer. 2025 Jan 1;131(1):e35694. doi: 10.1002/cncr.35694. Cancer. 2025. PMID: 39748467

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,774 results

Search Page

Filters